EP 2309995 A1 20110420 - PHARMACEUTICAL FORMULATION FOR LOWERING PULMONARY BLOOD PRESSURE
Title (en)
PHARMACEUTICAL FORMULATION FOR LOWERING PULMONARY BLOOD PRESSURE
Title (de)
PHARMAZEUTISCHE FORMULIERUNG ZUR PULMONALEN BLUTDRUCKSENKUNG
Title (fr)
FORMULATION PHARMACEUTIQUE POUR LA RÉDUCTION DE LA PRESSION ARTÉRIELLE PULMONAIRE
Publication
Application
Priority
- EP 2009005749 W 20090807
- DE 102008037324 A 20080811
Abstract (en)
[origin: CA2733651A1] The invention relates to pharmaceutical formulations for lowering pulmonary blood pressure, comprising micronized ambrisentan, preferably in the form of an intermediate, together with a hydrophilicizing agent. The invention further provides methods of producing pharmaceutical formulations comprising micronized ambrisentan.
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/505 (2006.01)
CPC (source: EP US)
A61K 9/145 (2013.01 - EP US); A61K 9/2054 (2013.01 - EP US); A61K 31/505 (2013.01 - EP US); A61K 31/513 (2013.01 - EP US); A61P 9/12 (2017.12 - EP); Y10T 428/2982 (2015.01 - EP US)
Citation (search report)
See references of WO 2010017917A1
Citation (examination)
EUROPEAN MEDICINES AGENCY (EMEA): "Assessment Report for Volibris", 1 April 2008 (2008-04-01), pages 1 - 44, XP055211575
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
DE 102008037324 A1 20100218; CA 2733651 A1 20100218; EP 2309995 A1 20110420; US 2011189243 A1 20110804; WO 2010017917 A1 20100218
DOCDB simple family (application)
DE 102008037324 A 20080811; CA 2733651 A 20090807; EP 09777743 A 20090807; EP 2009005749 W 20090807; US 200913055431 A 20090807